[Clinical trial with a nonamphetaminic anoretic].
The anorexigenic activity of a new compound tricyclic in nature and non-related to amphetamine, mazindol, was studied. The experiment was carried out in 20 patients (17 females and 3 males) aged 17-55 years with a minim overweight of 15% above ideal body weight. Simultaseously, another group of 20 patients (16 females and 4 males) aged 16-55 years with a minim overweight of 15% above ideal body weight were given placebo treatment. Both groups received treatment for a period of eight weeks.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008454:Mazindol / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*; D010919:Placebos; D013607:Tablets
D007211:Indoles; D010919:Placebos; D013607:Tablets; D008454:Mazindol
Ensayo clínico con un nuevo anorexígeno no anfetamínico